Alzheimer's disease (AD) causes gradual cognitive decline and dementia.
Until recently, the definitive diagnosis of AD was based on autopsy assessments of brain amyloid-β plaques and tau neurofibrillary tangles, the defining biological features of AD. Biomarkers of amyloid-β and tau are vital for measuring AD pathology in living people and for differentiating between different neurodegenerative diseases.
With the latest progress in AD research, accurate in-vivo diagnosis of AD is becoming increasingly crucial: before starting treatment with anti-amyloid therapies, it's essential to determine if amyloid positivity is present. This article...
Ellis reviews Parkinson's & Alzheimer's disease. This will include the signs/symptoms, diagnosis, and nursing care for both. At the end of the video,...